D G. Bebb

Calgary, AB, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Systematic Literature Review of the Prevalence and Prognostic Value of Delta-Like Ligand 3 Protein Expression in Small Cell Lung Cancer.

Systematic Literature Review of the Prevalence and Prognostic Value of Delta-Like Ligand 3 Protein Expression in Small Cell Lung Cancer.

Journal: Targeted oncology

Published: October 11, 2023

Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer.

Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer.

Journal: Journal of hematology & oncology

Published: April 05, 2023

Genome-wide Detection of Chimeric Transcripts in Early-stage Non-small Cell Lung Cancer.

Genome-wide Detection of Chimeric Transcripts in Early-stage Non-small Cell Lung Cancer.

Journal: Cancer genomics & proteomics

Published: January 04, 2023

A Comparison of Patients' and Physicians' Knowledge and Expectations Regarding Precision Oncology Tests.

A Comparison of Patients' and Physicians' Knowledge and Expectations Regarding Precision Oncology Tests.

Journal: Current oncology (Toronto, Ont.)

Published: September 01, 2022

Estimating the Impact of Delayed Access to Oncology Drugs on Patient Outcomes in Canada.

Estimating the Impact of Delayed Access to Oncology Drugs on Patient Outcomes in Canada.

Journal: Oncology and therapy

Published: December 08, 2021

Feasibility of a multimodal exercise, nutrition, and palliative care intervention in advanced lung cancer.

Feasibility of a multimodal exercise, nutrition, and palliative care intervention in advanced lung cancer.

Journal: BMC cancer

Published: October 06, 2020

A phase IB study of durvalumab with or without tremelimumab and platinum-doublet chemotherapy in advanced solid tumours: Canadian Cancer Trials Group Study IND226.

A phase IB study of durvalumab with or without tremelimumab and platinum-doublet chemotherapy in advanced solid tumours: Canadian Cancer Trials Group Study IND226.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 02, 2020

The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors.

The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors.

Journal: Cancers

Published: October 16, 2019

Health-related quality of life after curative-intent treatment of non-small cell lung cancer: can exercise lessen the burden?

Health-related quality of life after curative-intent treatment of non-small cell lung cancer: can exercise lessen the burden?

Journal: Annals of translational medicine

Published: January 08, 2019

Demographic and clinical correlates of accelerometer assessed physical activity and sedentary time in lung cancer survivors.

Demographic and clinical correlates of accelerometer assessed physical activity and sedentary time in lung cancer survivors.

Journal: Psycho-oncology

Published: March 09, 2017

Low Ki67/high ATM protein expression in malignant tumors predicts favorable prognosis in a retrospective study of early stage hormone receptor positive breast cancer.

Low Ki67/high ATM protein expression in malignant tumors predicts favorable prognosis in a retrospective study of early stage hormone receptor positive breast cancer.

Journal: Oncotarget

Published: August 26, 2016

Low ATM protein expression in malignant tumor as well as cancer-associated stroma are independent prognostic factors in a retrospective study of early-stage hormone-negative breast cancer.

Low ATM protein expression in malignant tumor as well as cancer-associated stroma are independent prognostic factors in a retrospective study of early-stage hormone-negative breast cancer.

Journal: Breast cancer research : BCR

Published: February 20, 2015

Showing 1-12 of 18

Last Updated: 09/26/2026